MacroGenics
MGNX
#9393
Rank
โ‚น7.78 B
Marketcap
โ‚น123.08
Share price
-0.72%
Change (1 day)
-57.13%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น6.01 Billion

According to MacroGenics's latest financial reports the company has โ‚น6.01 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น9.95 B-21.64%
2023-12-31$โ‚น12.70 B8.11%
2022-12-31$โ‚น11.75 B-34.11%
2021-12-31$โ‚น17.83 B-17.58%
2020-12-31$โ‚น21.63 B31.57%
2019-12-31$โ‚น16.44 B-3.16%
2018-12-31$โ‚น16.98 B-11.12%
2017-12-31$โ‚น19.10 B4.62%
2016-12-31$โ‚น18.26 B-12.29%
2015-12-31$โ‚น20.82 B170.89%
2014-12-31$โ‚น7.68 B57.67%
2013-12-31$โ‚น4.87 B-1180.96%
2012-12-31$-โ‚น0.46 Billion-51.24%
2011-12-31$-โ‚น0.93 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Xencor
XNCR
โ‚น56.17 B 833.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น8.363 T 138,847.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.663 T 77,371.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.927 T 31,923.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น864.13 B 14,256.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.142 T 35,497.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.670 T 27,660.78%๐Ÿ‡บ๐Ÿ‡ธ USA